1,210 reports of this reaction
1.4% of all AZITHROMYCIN reports
#18 most reported adverse reaction
WHEEZING is the #18 most commonly reported adverse reaction for AZITHROMYCIN, manufactured by AiPing Pharmaceutical, Inc.. There are 1,210 FDA adverse event reports linking AZITHROMYCIN to WHEEZING. This represents approximately 1.4% of all 88,134 adverse event reports for this drug.
Patients taking AZITHROMYCIN who experience wheezing should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
WHEEZING is a less commonly reported adverse event for AZITHROMYCIN, but still significant enough to appear in the safety profile.
In addition to wheezing, the following adverse reactions have been reported for AZITHROMYCIN:
The following drugs have also been linked to wheezing in FDA adverse event reports:
WHEEZING has been reported as an adverse event in 1,210 FDA reports for AZITHROMYCIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
WHEEZING accounts for approximately 1.4% of all adverse event reports for AZITHROMYCIN, making it a notable side effect.
If you experience wheezing while taking AZITHROMYCIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.